Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units*

Abstract

Meropenem exposure is associated with the highest risk of resistance development in P. aeruginosa. Increasing carbapenem use attributable to emergence of Gram-negative bacteria producing extended-spectrum β-lactamases will enhance antibiotic resistance in P. aeruginosa.